Dr. Reddy's Laboratories
Search results
5 days ago · Biocon is an innovation led fully integrated biopharmaceutical company that develop affordable biosimilars, generic formulations & complex APIs.
Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. [4] The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, [5] including the United States and Europe. [4]
A global biopharmaceutical company changing patients’ lives by finding new & affordable ways to treat diabetes, cancer & autoimmune diseases.
It’s a chance to work alongside some of the brightest minds in research, healthcare, pharmaceutical, biotechnology and business sectors. With a talented and diverse team, which works towards the common goal of making healthcare affordable and accessible globally, the possibilities are endless. MORE >>.
5 days ago · Biocon announced that its Bengaluru mAbs facility has been approved by the European Medicines Agency (EMA) to manufacture biosimilar ‘Bevacizumab’. It is a type of targeted cancer drug treatment.
2 days ago · Biocon Share Price Today (27 Jun, 2024): Biocon Stock Price (₹ 345.20) Live NSE/BSE updates on The Economic Times. Check out why Biocon share price is down today. Get all details on Biocon Ltd.shares news and analysis, Forecasts, Dividend, balance sheet, profit & loss, Quarterly results, annual report information, and more
Biocon is an innovation led fully integrated biopharmaceutical company that has developed affordable biosimilars, novel biologics and complex APIs. Leader in fermentation based biopharmaceuticals. Global scale manufacturing set up for biologics, biosimilars.
Get the latest Biocon Ltd (BIOCON) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Biocon Share Price: Find the latest news on Biocon Stock Price. Get all the information on Biocon with historic price charts for NSE / BSE.
Biocon Biologics Ltd on Monday announced that it has received approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab at its new multi-product monoclonal antibodies ...
